Gastric cancer is the fifth most common cancer, yet research and prevention efforts remain limited. Lorna Rothery spoke with Dr Jin Young Park, the leader of the Gastric Cancer Prevention Team at the International Agency for Research on Cancer, about the necessary steps for improvement.
Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Researchers have shown that AI can detect early laryngeal cancer and related lesions from voice recordings, offering a simple, non-invasive screening option.
Researchers have developed a lung cancer treatment that delivers healthy mitochondria to tumours, boosting T cell activity and improving the effectiveness of cisplatin chemotherapy with reduced toxicity.
The Lancet Commission finds that over three in five liver cancer cases are due to modifiable risks like hepatitis, alcohol, and obesity, highlighting urgent prevention needs.
The NHS Cancer Programme has awarded £14.4 million through SBRI Healthcare to support 16 pioneering projects aimed at improving early cancer detection and diagnosis across the UK.
UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
World Cancer Research Fund International (WCRFI) is a not-for-profit organisation that leads a network of cancer prevention charities, including the American Institute for Cancer Research, World Cancer Research Fund in the UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong. They are dedicated to funding research on cancer, specifically how diet, weight, and physical activity affect cancer risk and survival.
